IDXX
2025Q2BMOIDEXX Laboratories Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH
Street
Consensus EPS3.30
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move4.7%
IV front—
P/C full—
P/C front—
Features as of2025-08-01
Run-up
Close—
Ret 5d-5.2%
Ret 10d+4.1%
Ret 20d-2.1%
Ret 30d+3.0%
Actual EPS
3.63Beat
Estimated EPS3.30
Actual revenue
1.1B
Surprise %+10.0%
Beat / missBeat
Beat streak 44
Beat streak 88
Reaction
1-day stock reaction+3.1%
Implied vs actual
Implied 4.7%Actual 23.7%
Gap reaction+23.7%
Day result+27.5%
Next-day upYes
Realized / IV5.04×
Post tape
Post 5d-4.5%
Post 10d-6.6%
Post volume3.3M
Vol ×10d4.60×
Vol ×20d5.99×
Post range6.7%